On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...
Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
Zacks Investment Research on MSN
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
The CRISPR gene editing technology has transformed the research lab, and this powerful tool is now making its way into the clinic. So far, three different human diseases have been successfully treated ...
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...
The Cool Down on MSN
Researchers harness gene-editing to revolutionize how we grow food: 'We think that is a technology that can work'
As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...
In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $68.29, indicating a -6.54% shift from the previous trading day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback